Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Brief Somalia.
Press releases published on September 10, 2025
Ernexa Therapeutics Provides Update on Operational Excellence and Performance
CAMBRIDGE, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today provided an update on its operational excellence and …
FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies
HOUSTON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …
JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation
IRVINE, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that the newly published guidelines from the European Society of Cardiology ( …
Catheter Precision Announces Tender Win and First Purchase Order in Croatia
FORT MILL, S.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced that it …
Picard Announces Appointment of Two New Members to its Board of Directors
TUCSON, Ariz., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first U.S. and Canadian commercially-approved total artificial heart, …
DeepView® System highlighted at the European Burns Association Congress
DALLAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today …
National Fitness Partners and Penn State Athletics Continue the Fight Against Pediatric Cancer with 2025 “Sack for a Cure” Initiative
CAMP HILL, Pa., Sept. 10, 2025 (GLOBE NEWSWIRE) -- National Fitness Partners (“NFP”), a leading Planet Fitness franchise division and proud partner of Penn State Athletics, today announced the return of its “Sack for a Cure” initiative to benefit Penn …
Beacon Therapeutics to Participate in the 2025 Bank of America Healthcare Trailblazers Private Company Conference
LONDON and CAMBRIDGE, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited (‘Beacon Therapeutics’ or ‘the Company’), a leading clinical-stage biotechnology company with a mission to save and restore vision in people with rare and …
CoRegen, Inc. Strengthens Leadership Team with the Appointments of Sonja Nelson as Chief Financial Officer and Peter Gelinas as Chief Technical Officer
HOUSTON, Sept. 10, 2025 (GLOBE NEWSWIRE) -- CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients impacted by some of the most aggressive forms of cancer, today announced the appointments of Sonja Nelson as Chief Financial …
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Panna Sharma, CEO of AI-Driven Biotech Focused on Challenging & Rare Cancers, Lantern Pharma Inc. (LTRN)
AUSTIN, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire …
Kriya Announces $320 Million Series D Financing to Advance Pipeline of Gene Therapies for Chronic Diseases of High Unmet Need
RESEARCH TRIANGLE PARK, N.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Kriya Therapeutics, Inc. (“Kriya”), a clinical-stage biopharmaceutical company developing gene therapies to address common chronic diseases of high unmet need, today announced the closing of …
California Schools Get Roadmap to Millions in Mental Health Funding — Anaheim Elementary Unlocks Over $700K Using TadHealth
ANAHEIM, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Anaheim Elementary School District (AESD), in partnership with TadHealth, a purpose-built school-based Electronic Health Record (EHR) and claims engine built for the Children and Youth Behavioral Health …
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes
Type 2 diabetes (T2DM), affecting more than 530 million worldwide, is a metabolic disease often coupled with cardiovascular complications including coronary artery disease, heart failure, and stroke. Cardiovascular complications are a leading cause of …
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI® (ublituximab-xiiy) data in patients with relapsing forms of multiple sclerosis (RMS), at the …
Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN® at upcoming 150th Annual Meeting of the American Neurological Association
Poster presentation will feature new data for SYMPAZAN, the only FDA-approved oral film formulation of clobazam for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome in patients two years of age or older Abstract is now available on …
Royalty Pharma Announces Release of Deloitte’s Report on the Biopharma Royalty Market
First of its kind report offers insight from over 110 biopharma executives into the benefits of royalties, current market dynamics and outlook for royalty market expansion Royalties have become integral to biopharma’s diversified capital landscape driven …
Three CorVel Partners Recognized as 2025 Theo Award Winners for Excellence in Workers’ Compensation
FORT WORTH, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Today, CorVel Corporation (NASDAQ: CRVL), a national provider of risk management solutions, is proud to announce that Sharp HealthCare, the State of North Carolina, and The Save Mart Companies have been …
Relmada Issues Mid-Year CEO Letter to Shareholders
CORAL GABLES, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology-related and central nervous system indications, …
Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting
PONTE VERDE, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, …
Purespring Therapeutics to Participate in the 2025 BofA Healthcare Trailblazers Private Company Conference
London – 10 September 2025 - Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, today announced that members of its management team will participate in the 2025 Bank of America Healthcare …